US FDA approves first drug for fatty liver disease NASH ...Middle East

The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as non-alcoholic steatohepatitis (NASH), the first treatment to get the nod for the condition and opening up a multi-billion opportunity. The company's oral drug, called Rezdiffra, has been approved for patients who have NASH with fibrosis, or scarring, that has progressed to stage 2 or 3 in severity, according to an FDA label released on Thursday.

Hence then, the article about us fda approves first drug for fatty liver disease nash was published today ( Thursday 14/03/2024 - 11:12 PM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA approves first drug for fatty liver disease NASH )

Also on site :

• Group has twisted the meaning of ‘genocide’ — and hijacked a Zionist hero’s name — to suit its own woke purposes
• This Mother’s Day, don’t forget about the supermoms: grandmas